CIK 0001408443 · Non-accelerated filer<br>Smaller reporting company
Milestone Pharmaceuticals Inc.
Sign in to watch- Ticker
- MIST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Quebec, Canada
- Entity type
- operating
- Phone
- (514) 336-0444
- Business address
- 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, Quebec, Canada, H4M 2X6
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-28 | Wills Robert James Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2024-07-15 | Saik Andrew Director | Grant or award · Stock Option (right to buy) | −80,000 | 80,000 | ||
| 2024-07-15 | Duty Stuart Director | Grant or award · Stock Option (right to buy) | −80,000 | 80,000 | ||
| 2023-06-07 | Wills Robert James Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-06-07 | TOMSICEK MICHAEL JOHN Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-06-07 | Pasternak Richard C Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-06-07 | Liebert Debra K. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-06-07 | Giles Lisa M. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-06-07 | Fischer Seth H. Z. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2023-03-22 | RTW INVESTMENTS, LP 10% owner | Other disposition | −1,059,000 | 3,256,102 | ||
| 2023-03-21 | Fischer Seth H. Z. Director | Grant or award · Stock Option (right to buy) | +42,000 | 42,000 | ||
| 2023-02-16 | Muller Lorenz Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2023-02-16 | Nelson Jeffrey Edward Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2023-02-16 | Hasija Amit CFO & EVP of Corp. Development | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2023-02-16 | Bharucha David Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +185,000 | 185,000 | ||
| 2023-02-16 | Oliveto Joseph President and CEO | Grant or award · Employee Stock Option (right to buy) | +360,000 | 360,000 | ||
| 2022-12-05 | Bharucha David Chief Medical Officer | Purchase | +7,000 | $4.69 | $33K | 10,000 |
| 2022-12-01 | Bharucha David Chief Medical Officer | Purchase | +3,000 | $4.86 | $15K | 3,000 |
| 2022-10-21 | Liebert Debra K. Director | Purchase | +4,000 | $5.26 | $21K | 4,000 |
| 2022-10-20 | Pasternak Richard C Director | Purchase | +10,000 | $5.20 | $52K | 10,000 |
Page 6 of 9 · 163 trades